Aberrant pain modulation in trigeminal neuralgia patients

Area of Science:

• Neuroscience
• Pain Research
• Endocrinology

Background:

• Trigeminal neuralgia (TN) is a chronic pain condition affecting the trigeminal nerve.
• Supraspinal pain modulation plays a crucial role in pain perception and regulation.
• Neuromodulators like Calcitonin Gene-Related Peptide and beta-endorphin are implicated in pain pathways.

Purpose of the Study:

• To investigate supraspinal pain modulation in typical TN patients using a conditioned pain modulation (CPM) paradigm.
• To assess the role of Calcitonin Gene-Related Peptide and beta-endorphin in TN pathogenesis and pain modulation.
• To compare CPM responses and neuromodulator levels between TN patients and healthy controls.

Main Methods:

• Twenty TN patients and 20 age/gender-matched healthy controls participated.
• Hot pain thresholds (HPT) were measured on the face before, during, and after cold-water immersion of the contralateral foot (CPM).
• Plasma levels of Calcitonin Gene-Related Peptide and beta-endorphin were quantified.

Main Results:

• Healthy controls exhibited significantly greater HPT changes during CPM compared to TN patients (p<0.0001).
• The CPM effect in TN patients was significant only in the 2nd and 3rd minutes post-immersion, while it lasted until the 4th minute in controls.
• Plasma beta-endorphin levels were significantly lower in TN patients than in healthy controls (p=0.003).

Conclusions:

• TN patients demonstrate impaired supraspinal pain modulation, also known as Diffuse Noxious Inhibitory Controls (DNIC).
• Reduced beta-endorphin levels may be a contributing factor to the chronic pain experienced by TN patients.
• These findings highlight potential therapeutic targets for managing TN pain.